Ernexa Therapeutics Inc (ERNA): Next-Year EPS Estimate 89.68%
As of 2026-09-25, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 89.68%. Featured in 3 EPS revision reports, most recently on 2026-05-19.
Analyst estimates for ERNA have remained steady in the most recent observable window, with next-year EPS growth projected at 89.68%. Current-year growth stands at 67.76%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 89.68%
- EPS growth this year
- 67.76%
- EPS next quarter (est)
- -$3.84
- Last price
- $3.44
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-25 | 89.68% | 67.76% | -$3.84 | $3.44 |
| 2026-09-24 | 89.68% | 67.76% | -$3.84 | $3.62 |
| 2026-09-23 | 89.68% | 67.76% | -$3.84 | $3.65 |
| 2026-09-22 | 89.68% | 67.76% | -$3.84 | $3.80 |
| 2026-09-21 | 89.68% | 67.76% | -$3.84 | $3.96 |
| 2026-09-20 | 89.68% | 67.76% | -$3.84 | $3.83 |
| 2026-09-18 | 89.68% | 67.76% | -$3.84 | $3.83 |
| 2026-09-17 | 89.68% | 67.76% | -$3.84 | $3.76 |
| 2026-09-16 | 89.68% | 67.76% | -$3.84 | $3.91 |
| 2026-09-15 | 89.68% | 67.76% | -$3.84 | $4.08 |
| 2026-09-14 | 89.68% | 67.76% | -$3.84 | $4.27 |
| 2026-09-13 | 89.68% | 67.76% | -$3.84 | $4.16 |
| 2026-09-11 | 89.68% | 67.76% | -$3.84 | $4.16 |
| 2026-09-10 | 89.68% | 67.76% | -$3.84 | $4.02 |
| 2026-09-09 | 89.68% | 67.76% | -$3.84 | $4.02 |
| 2026-09-08 | 89.68% | 67.76% | -$3.84 | $4.19 |
| 2026-09-07 | 89.68% | 67.76% | -$3.84 | $4.31 |
| 2026-09-06 | 89.68% | 67.76% | -$3.84 | $4.31 |
| 2026-09-04 | 89.68% | 67.76% | -$3.84 | $4.31 |
| 2026-09-03 | 89.68% | 67.76% | -$3.84 | $4.53 |
| 2026-09-02 | 89.68% | 67.76% | -$3.84 | $4.54 |
| 2026-09-01 | 89.68% | 67.76% | -$3.84 | $4.35 |
| 2026-08-31 | 89.68% | 67.76% | -$3.30 | $4.57 |
| 2026-08-30 | 89.68% | 67.76% | -$3.30 | $4.57 |
| 2026-08-29 | 89.68% | 67.76% | -$3.30 | $4.57 |
| 2026-08-28 | 89.68% | 67.76% | -$3.30 | $4.57 |
| 2026-08-27 | 89.68% | 67.76% | -$3.30 | $4.74 |
| 2026-08-26 | 89.68% | 67.76% | -$3.30 | $4.89 |
| 2026-08-25 | 89.68% | 67.76% | -$3.30 | $4.93 |
| 2026-08-24 | 89.68% | 67.76% | -$3.30 | $5.03 |
Reports Featuring ERNA
Screen Performance
Aggregate stats across all 2051 tickers our top-EPS-revision screen has flagged over the past 177 days.
- Median return since detection
- +0.0%
- % of tickers in the green
- 50%
- Median return on winners
- +22.6%
- Large revisions captured
- 1770
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Ernexa Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-09-25, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 89.68%, based on analyst consensus.
What sector and industry does Ernexa Therapeutics Inc belong to?▾
Ernexa Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ERNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ernexa Therapeutics Inc (ERNA) appears here because it was detected by our daily top-EPS-revision-performer screen.